Background: Reliable neurofunctional markers of increased vulnerability to psychosis are needed to improve the predictive value of psychosis risk syndrome and inform preventive interventions. Methods: I performed a signed differential mapping (SDM) voxel-wise meta-analysis of functional magnetic resonance imaging (fMRI) studies of patients at clinical high risk for psychosis. Results: Ten studies were included in the analysis. Compared with controls, high-risk patients showed reduced neural activation in the left inferior frontal gyrus (Brodmann area [BA] 9) and in a cluster spanning the bilateral medial frontal gyrus (BA 8,6), bilateral superior frontal gyrus (BA 8,6) and the left anterior cingulate (BA 32). There was no publication bias. ...
Importance: The ENIGMA clinical high risk (CHR) for psychosis initiative, the largest pooled neuroim...
Objective: Prefrontal cortical dysfunction has been implicated in the pathophysiology of schizophren...
: Neuroimaging findings in people at either genetic risk or at clinical high-risk for psychosis (CHR...
Background: Individual structural imaging studies in the pre-psychotic phases deliver contrasting fi...
Background: Despite impressive advancements in early interventions in psychosis, there is an urgent ...
Objectives: In early stage psychosis research the identification of neurobiological correlates of vu...
Individuals at clinical high risk (CHR) of developing psychosis present with widespread functional a...
Computational brain-imaging studies of individuals at familial high risk for psychosis have provided...
The ability to identify biomarkers of psychosis risk is essential in defining effective preventive m...
Background: Several studies have indicated that people with prodromal signs of psychosis show altera...
Objective: To examine the association between baseline alterations in grey matter volume (GMV) and c...
An understanding of the neurobiological correlates of vulnerability to psychosis is fundamental to r...
Background: Recent evidence has revealed abnormal functional connectivity between the frontal and pa...
Objective. To address at a meta-analytical level the neuroanatomical markers of genetic liability to...
Importance: The ENIGMA clinical high risk (CHR) for psychosis initiative, the largest pooled neuroim...
Importance: The ENIGMA clinical high risk (CHR) for psychosis initiative, the largest pooled neuroim...
Objective: Prefrontal cortical dysfunction has been implicated in the pathophysiology of schizophren...
: Neuroimaging findings in people at either genetic risk or at clinical high-risk for psychosis (CHR...
Background: Individual structural imaging studies in the pre-psychotic phases deliver contrasting fi...
Background: Despite impressive advancements in early interventions in psychosis, there is an urgent ...
Objectives: In early stage psychosis research the identification of neurobiological correlates of vu...
Individuals at clinical high risk (CHR) of developing psychosis present with widespread functional a...
Computational brain-imaging studies of individuals at familial high risk for psychosis have provided...
The ability to identify biomarkers of psychosis risk is essential in defining effective preventive m...
Background: Several studies have indicated that people with prodromal signs of psychosis show altera...
Objective: To examine the association between baseline alterations in grey matter volume (GMV) and c...
An understanding of the neurobiological correlates of vulnerability to psychosis is fundamental to r...
Background: Recent evidence has revealed abnormal functional connectivity between the frontal and pa...
Objective. To address at a meta-analytical level the neuroanatomical markers of genetic liability to...
Importance: The ENIGMA clinical high risk (CHR) for psychosis initiative, the largest pooled neuroim...
Importance: The ENIGMA clinical high risk (CHR) for psychosis initiative, the largest pooled neuroim...
Objective: Prefrontal cortical dysfunction has been implicated in the pathophysiology of schizophren...
: Neuroimaging findings in people at either genetic risk or at clinical high-risk for psychosis (CHR...